Ensitrelvir for COVID-19
50th treatment shown to reduce risk in
July 2023, now with p = 0.036 from 10 studies, recognized in 2 countries.
No treatment is 100% effective.
Protocols combine treatments.
RCT 40 long COVID patients in the USA, showing no significant improvement with ensitrelvir.
Henrich et al., 2 Apr 2026, Double Blind Randomized Controlled Trial, placebo-controlled, USA, preprint, 1 author, trial NCT06161688 (history) (PREVAIL-LC).
Late treatment
is less effective
is less effective
